Molina Healthcare, Inc. (NYSE:MOH) Holdings Raised by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc lifted its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 100.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,523 shares of the company’s stock after purchasing an additional 27,852 shares during the quarter. Ensign Peak Advisors Inc owned about 0.10% of Molina Healthcare worth $16,160,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Ethic Inc. raised its stake in shares of Molina Healthcare by 68.2% during the fourth quarter. Ethic Inc. now owns 5,193 shares of the company’s stock valued at $1,511,000 after purchasing an additional 2,106 shares in the last quarter. FORA Capital LLC bought a new stake in shares of Molina Healthcare during the fourth quarter valued at about $1,579,000. Deutsche Bank AG raised its stake in shares of Molina Healthcare by 12.6% during the fourth quarter. Deutsche Bank AG now owns 338,460 shares of the company’s stock valued at $98,509,000 after purchasing an additional 37,941 shares in the last quarter. Dean Capital Management raised its stake in shares of Molina Healthcare by 1.6% during the fourth quarter. Dean Capital Management now owns 5,164 shares of the company’s stock valued at $1,503,000 after purchasing an additional 82 shares in the last quarter. Finally, Colonial Trust Co SC raised its stake in shares of Molina Healthcare by 930.0% during the fourth quarter. Colonial Trust Co SC now owns 103 shares of the company’s stock valued at $30,000 after purchasing an additional 93 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of recent analyst reports. UBS Group cut their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Robert W. Baird reiterated a “neutral” rating and issued a $375.00 price target (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Truist Financial boosted their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. StockNews.com upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, April 11th. Finally, Baird R W cut shares of Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $365.38.

Insider Buying and Selling at Molina Healthcare

In related news, CEO Joseph M. Zubretsky sold 87,500 shares of the business’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares of the company’s stock, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard M. Schapiro sold 669 shares of the business’s stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director now directly owns 11,244 shares of the company’s stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 89,169 shares of company stock valued at $28,520,995 in the last 90 days. 1.10% of the stock is currently owned by corporate insiders.

Molina Healthcare Trading Down 0.6%

Shares of MOH opened at $323.84 on Monday. The business’s 50-day moving average price is $324.73 and its 200 day moving average price is $308.38. The stock has a market capitalization of $17.55 billion, a P/E ratio of 15.85, a P/E/G ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a 1-year low of $262.32 and a 1-year high of $365.23. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company had revenue of $11.15 billion for the quarter, compared to analysts’ expectations of $10.86 billion. During the same quarter in the previous year, the business posted $5.73 EPS. The business’s revenue for the quarter was up 12.2% on a year-over-year basis. Analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.